{
    "organizations": [],
    "uuid": "cf3300de48515ab66347bf8d4ca61b15902391ee",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-shanghai-fosun-plans-us-jv-to-boos/brief-shanghai-fosun-plans-u-s-jv-to-boost-capital-of-shanghai-biotech-firm-idUSH9N1P400W",
    "ord_in_thread": 0,
    "title": "BRIEF-Shanghai Fosun Plans U.S. JV, To Boost Capital Of Shanghai Biotech Firm",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 10 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd:\n* SAYS UNIT PLANS TO INVEST $25.5 MILLION TO SET UP JV IN THE U.S.\n* SAYS IT PLANS TO BOOST CAPITAL OF SHANGHAI BIOTECH FIRM BY 102 MILLION YUAN ($15.68 million) Source text in Chinese: bit.ly/2ALO7nS Further company coverage: ($1 = 6.5050 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-01-10T18:56:00.000+02:00",
    "crawled": "2018-01-11T12:43:24.007+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "shanghai",
        "fosun",
        "pharmaceutical",
        "group",
        "co",
        "ltd",
        "say",
        "unit",
        "plan",
        "invest",
        "million",
        "set",
        "jv",
        "say",
        "plan",
        "boost",
        "capital",
        "shanghai",
        "biotech",
        "firm",
        "million",
        "yuan",
        "million",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "chinese",
        "yuan",
        "renminbi",
        "reporting",
        "hong",
        "kong",
        "newsroom",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}